Search - tctmd.com

Displaying 401 - 420 of 722

Sort: Relevancy | Date

Presentation TCT 2015

TCT 88: Transcatheter Perivascular Chemical Neurolysis to Produce Renal Denervation Targeted, Local Delivery of Alcohol as a Viable Alternative to Radiofrequency Approaches

Presenter: Michael A. Weber, Stephen G. Worthley, Tim A. Fischell

October 13, 2015

Presentation TCT 2015

TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results

Presenter: Michael A. Weber, Stephen G. Worthley, Roland E Schmieder

October 13, 2015

Presentation TCT 2015

TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study

Presenter: Michael A. Weber, Stephen G. Worthley

October 13, 2015

Presentation TCT 2015

TCT 85: Safety and Performance of the EnligHTN Renal Denervation System in Patients With Severe Uncontrolled Hypertension Twelve-Month Results From the EnligHTN II Study

Presenter: Michael A. Weber, Stephen G. Worthley, Melvin D. Lobo

October 13, 2015

Presentation TCT 2015

TCT 84: Enhanced Circumferential Ablation Using a Multielectrode Bipolar/Unipolar Over-the-Wire Renal Denervation RF Catheter System With Closed-Loop Sensing

Presenter: Michael A. Weber, Stephen G. Worthley, Elazer R. Edelman

October 13, 2015

Presentation TCT 2015

TCT 83: Long-term (24-Month) Blood Pressure Results of Catheter-Based Renal Artery Denervation SYMPLICITY HTN-3 Randomized Controlled Trial

Presenter: Michael A. Weber, Stephen G. Worthley, Deepak L. Bhatt

October 13, 2015

Presentation TCT 2015

Guidewire-Based Autonomic Neural Sensing From the Artery Lumen: Applications in Renal Denervation, Cancer, and Dysautonomias (Autonomix)

Presenter: Robert S. Schwartz

October 13, 2015

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

News Industry News

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

October 12, 2015

Presentation TCT 2015

Rox: Percutaneous Fistula Creation

Presenter: C. Venkata S. Ram, Krishna J. Rocha-Singh, Thomas Zeller

October 11, 2015

Presentation TCT 2015

Mobius HD: A Self-Expanding Carotid Implant

Presenter: C. Venkata S. Ram, Krishna J. Rocha-Singh, Thomas Zeller, Farrell O. Mendelsohn

October 11, 2015

Presentation TCT 2015

Baroreceptor Stimulation: CVRx and Beyond

Presenter: C. Venkata S. Ram, Krishna J. Rocha-Singh, Thomas Zeller, Atul Pathak

October 11, 2015

Presentation TCT 2015

Ablative Solutions (Chemical Neurolysis)

Presenter: C. Venkata S. Ram, Krishna J. Rocha-Singh, Thomas Zeller, Wojtek Wojakowski

October 11, 2015

Presentation TCT 2015

Nonvascular Renal Denervation (Verve)

Presenter: C. Venkata S. Ram, Krishna J. Rocha-Singh, Thomas Zeller, Richard R. Heuser

October 11, 2015

Presentation TCT 2015

From SYMPLICITY HTN-3 to Ongoing Renal Denervation Studies: What Answers Can We Expect (and Not Expect) From the Ongoing RDN Studies?

Presenter: Ori Ben-Yehuda, Ajay J. Kirtane

October 11, 2015

Presentation TCT 2015

Denervx Microwave for Denervation

Presenter: C. Venkata S. Ram, Krishna J. Rocha-Singh, Thomas Zeller, Stefan C. Bertog

October 11, 2015

Presentation TCT 2015

Kona Noninvasive Therapy System

Presenter: C. Venkata S. Ram, Krishna J. Rocha-Singh, Thomas Zeller, Roland E Schmieder

October 11, 2015

Presentation TCT 2015

Keynote Lecture: If I Had Uncontrolled Hypertension

Presenter: Farrell O. Mendelsohn, William B. White, Horst Sievert

October 11, 2015

Presentation TCT 2015

Recors Trial Program

Presenter: Farrell O. Mendelsohn, William B. White, Laura Mauri

October 11, 2015

Presentation TCT 2015

Update on St. Judes Trial

Presenter: Farrell O. Mendelsohn, William B. White, William A. Gray

October 11, 2015

Advertisement

TCT 88: Transcatheter Perivascular Chemical Neurolysis to Produce Renal Denervation Targeted, Local Delivery of Alcohol as a Viable Alternative to Radiofrequency Approaches

TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results

TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study

TCT 85: Safety and Performance of the EnligHTN Renal Denervation System in Patients With Severe Uncontrolled Hypertension Twelve-Month Results From the EnligHTN II Study

TCT 84: Enhanced Circumferential Ablation Using a Multielectrode Bipolar/Unipolar Over-the-Wire Renal Denervation RF Catheter System With Closed-Loop Sensing

TCT 83: Long-term (24-Month) Blood Pressure Results of Catheter-Based Renal Artery Denervation SYMPLICITY HTN-3 Randomized Controlled Trial

Guidewire-Based Autonomic Neural Sensing From the Artery Lumen: Applications in Renal Denervation, Cancer, and Dysautonomias (Autonomix)

Companies With Innovative Technologies Compete in TCT Shark Tank

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

Rox: Percutaneous Fistula Creation

Mobius HD: A Self-Expanding Carotid Implant

Baroreceptor Stimulation: CVRx and Beyond

Ablative Solutions (Chemical Neurolysis)

Nonvascular Renal Denervation (Verve)

From SYMPLICITY HTN-3 to Ongoing Renal Denervation Studies: What Answers Can We Expect (and Not Expect) From the Ongoing RDN Studies?

Denervx Microwave for Denervation

Kona Noninvasive Therapy System

Keynote Lecture: If I Had Uncontrolled Hypertension

Recors Trial Program

Update on St. Judes Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content